Related Experiment Video
Updated: May 14, 2026

10:16
Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents
Published on: August 16, 2024
Sample concentration and purification for point-of-care diagnostics
Nga T Ho1, Andy Fan, Catherine M Klapperich
1Boston University, Department of Biomedical Engineering, USA. nho2311@bu.edu
Summary
This study presents a novel microfluidic chip for concentrating biological samples. The device effectively removes proteins and maintains electrolyte balance, improving detection limits for infectious disease diagnostics like Human Immunodeficiency Virus (HIV).
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Microfluidics
Background:
- Concentrating target analytes enhances biosensing sensitivity for infectious disease diagnosis.
- Evaporation-based concentration is effective but challenged by high protein and electrolyte levels in human samples like plasma.
- Protein dehydration and electrolyte imbalance can lead to sample gelling and pathogen lysis, hindering detection.
Purpose of the Study:
- To develop a microfluidic chip integrating dialysis and concentration for efficient sample preparation.
- To overcome limitations of traditional evaporation methods for complex biological samples.
- To improve the limit of detection for biosensing techniques, particularly for viral load testing.
Main Methods:
- Fabrication of a microfluidic chip combining dialysis and concentration functionalities.
- Processing of plasma or serum samples to remove proteins and adjust electrolyte concentrations.
- Demonstration of sample concentration by a factor of 10 in under 30 minutes.
Main Results:
- The microfluidic chip successfully dialyzed proteins while maintaining optimal electrolyte concentrations.
- Achieved a 10-fold concentration of plasma or serum samples within 30 minutes.
- Demonstrated proof-of-concept using a defective Human Immunodeficiency Virus (HIV) sample.
Conclusions:
- The developed microfluidic chip offers an effective solution for sample preparation in biosensing.
- This technology has the potential to significantly improve the sensitivity of molecular point-of-care viral load tests.
- Enables more accurate detection of low viral loads, crucial for managing conditions like HIV infection.

